NVNO enVVeno Medical Corporation
8.200USD+2.37%Mkt Cap: 5.70M $P/E: —2d ago
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The compa…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap5.70M USD
Enterprise Value-15.38M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-19.47M USD
Revenue/Share—
Last Price8.200 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees33
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.32
PEG—
EV/EBITDA0.89
EV/Revenue—
P/S—
P/B0.27
EPS (TTM)-24.99
EPS (Forward)-6.22
52W Range
7.0104% of range35.70
52W High35.70 USD
52W Low7.010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-71.77%
ROA-65.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.57M USD
CapEx (TTM)5.00K USD
FCF Margin—
FCF Yield-168.33%
Net Debt-20.98M USD
Net Debt/EBITDA1.22
Balance Sheet
Debt/Equity0.03
Current Ratio11.70
Quick Ratio11.39
Book Value/Sh30.71 USD
Cash/Share31.47 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateNov 30, 2020
Splits
Last Split1:35
Split DateJan 20, 2026
Analyst Consensus
Rating—
Target (Mean)30.00 USD
Upside (mean)+265.9%
Target Range30.00 USD – 30.00 USD
# Analysts1
Ownership
Shares Out.694.83K
Float590.41K
Insiders8.23%
Institutions15.96%
Short Interest
Short Ratio0.3d
Short % Float1.36%
Short % Out.1.35%
Shares Short9.38K
Short (prev mo.)24.40K
Technical
SMA 5010.19 (-19.5%)
SMA 20010.73 (-23.6%)
Beta1.29
S&P 52W Chg16.45%
Avg Vol (30d)25.40K
Avg Vol (10d)20.12K
Technical Indicators
RSI (14)35.3
MACD-0.6867
MACD Signal-0.5922
MACD Hist.-0.0945
BB Upper11.67 USD
BB Middle9.288 USD
BB Lower6.906 USD
BB Width51.30%
ATR (14)0.7739 USD
Vol Ratio (20d)1.27x